New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective

The Lancet Infectious Diseases

Volumn 16, Issue 12, 2016, Pages e276-e287

  Allegranzi, Benedetta ^a   Bischoff, Peter ^b   de Jonge, Stijn ^c   Kubilay, N Zeynep ^a   Zayed, Bassim ^a   Gomes, Stacey M ^d   Abbas, Mohamed ^e   Atema, Jasper J ^c   Gans, Sarah ^c   van Rijen, Miranda ^f   Boermeester, Marja A ^c   Egger, Matthias ^g   Kluytmans, Jan ^f,h   Pittet, Didier ^e   Solomkin, Joseph S ^d,i  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Oasis Global   (United States)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f AMPHIA HOSPITAL   (Netherlands)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; IMMUNOSUPPRESSIVE AGENT; PSEUDOMONIC ACID; SURGICAL GLUE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BATH; DRUG USE; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; HAIR REMOVAL; HAND WASHING; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INTESTINE PREPARATION; META ANALYSIS (TOPIC); NONHUMAN; NUTRITIONAL SUPPORT; PATIENT PREFERENCE; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARDIZATION; SURGICAL INFECTION; WORLD HEALTH ORGANIZATION; CONSENSUS; ECONOMICS; EVIDENCE BASED MEDICINE; GLOBAL HEALTH; INFECTION CONTROL; PROCEDURES; RISK FACTOR; STANDARDS; SURGICAL WOUND INFECTION;

CONSENSUS; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; INFECTION CONTROL; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; RISK FACTORS; SURGICAL WOUND INFECTION; WORLD HEALTH ORGANIZATION;

EID: 85004039876     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30398-X     Document Type: Review

References (148)

1. 1 WHO. Report on the burden of endemic health care-associated infection worldwide, 2011, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf (accessed Oct 9, 2016).
2. 2 Allegranzi, B, Bagheri Nejad, S, Combescure, C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377 (2011), 228–241.
3. 3 Bagheri Nejad, S, Allegranzi, B, Syed, SB, Ellis, B, Pittet, D, Health-care-associated infection in Africa: a systematic review. Bull World Health Organ 89 (2011), 757–765.
4. 4 ECDC. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2013, European Centre for Disease Prevention and Control, Stockholm http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf (accessed Oct 9, 2016).
5. 5 Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370 (2014), 1198–1208.
6. 6 WHO. WHO handbook for guideline development, 2012, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf (accessed Oct 9, 2016).
7. 7 Huang, X, Lin, J, Demner-Fushman, D, Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc 2006 (2006), 359–363.
8. 8 Liberati, A, Altman, DG, Tetzlaff, J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, 2009, b2700.
9. 9 Higgins, JP, Altman, DG, Gøtzsche, PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
10. 10 Wells, GA, Shea, B, O'Connell, D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2011, The Ottawa Hospital Research Institute, Ottawa http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed June 9, 2016).
11. 11 Balshem, H, Helfand, M, Schünemann, HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64 (2011), 401–406.
12. 12 Guyatt, G, Oxman, AD, Akl, EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
13. 13 Allegranzi, B, Zayed, B, Bischoff, P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis, 2016 published online Nov 2. http://dx.doi.org/10.1016/S1473-3099(16)30402-9.
14. 14 Berthold, E, Geborek, P, Gülfe, A, Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures. Acta Orthop 84 (2013), 495–501.
15. 15 Bafford, AC, Powers, S, Ha, C, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol 47 (2013), 491–495.
16. 16 Sany, J, Anaya, JM, Canovas, F, et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 20 (1993), 1129–1132.
17. 17 Grennan, DM, Gray, J, Loudon, J, Fear, S, Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60 (2001), 214–217.
18. 18 Bridges, SL Jr, López-Méndez, A, Han, KH, Tracy, IC, Alarcón, GS, Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?. J Rheumatol 18 (1991), 984–988.
19. 19 Carpenter, MT, West, SG, Vogelgesang, SA, Casey Jones, DE, Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19 (1996), 207–210.
20. 20 Colombel, JF, Loftus, EV Jr, Tremaine, WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99 (2004), 878–883.
21. 21 den Broeder, AA, Creemers, MC, Fransen, J, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 34 (2007), 689–695.
22. 22 Murata, K, Yasuda, T, Ito, H, Yoshida, M, Shimizu, M, Nakamura, T, Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod Rheumatol 16 (2006), 14–19.
23. 23 Di Carlo, V, Gianotti, L, Balzano, G, Zerbi, A, Braga, M, Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 16 (1999), 320–326.
24. 24 Culebras, JM, Malnutrition in the twenty-first century: an epidemic affecting surgical outcome. Surg Infect (Larchmt) 14 (2013), 237–243.
25. 25 Çelik, JB, Gezginç, K, Özçelik, K, Çelik, Ç, The role of immunonutrition in gynecologic oncologic surgery. Eur J Gynaecol Oncol 30 (2009), 418–421.
26. 26 Falewee, MN, Schilf, A, Boufflers, E, et al. Reduced infections with perioperative immunonutrition in head and neck cancer: exploratory results of a multicenter, prospective, randomized, double-blind study. Clin Nutr 33 (2014), 776–784.
27. 27 Fujitani, K, Tsujinaka, T, Fujita, J, et al. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer. Br J Surg 99 (2012), 621–629.
28. 28 Gianotti, L, Braga, M, Nespoli, L, Radaelli, G, Beneduce, A, Di Carlo, V, A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122 (2002), 1763–1770.
29. 29 Klek, S, Sierzega, M, Szybinski, P, et al. The immunomodulating enteral nutrition in malnourished surgical patients—a prospective, randomized, double-blind clinical trial. Clin Nutr 30 (2011), 282–288.
30. 30 Snyderman, CH, Kachman, K, Molseed, L, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 109 (1999), 915–921.
31. 31 Tepaske, R, Velthuis, H, Oudemans-van Straaten, HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 358 (2001), 696–701.
32. 32 Tepaske, R, te Velthuis, H, Oudemans-van Straaten, HM, et al. Glycine does not add to the beneficial effects of perioperative oral immune-enhancing nutrition supplements in high-risk cardiac surgery patients. JPEN J Parenter Enteral Nutr 31 (2007), 173–180.
33. 33 Horie, H, Okada, M, Kojima, M, Nagai, H, Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition. Surg Today 36 (2006), 1063–1068.
34. 34 Takeuchi, H, Ikeuchi, S, Kawaguchi, Y, et al. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg 31 (2007), 2160–2167.
35. 35 Casas-Rodera, P, Gómez-Candela, C, Benítez, S, et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial. Nutr Hosp 23 (2008), 105–110.
36. 36 de Luis, DA, Aller, R, Izaola, O, Cuellar, L, Terroba, MC, Postsurgery enteral nutrition in head and neck cancer patients. Eur J Clin Nutr 56 (2002), 1126–1129.
37. 37 de Luis, DA, Izaola, O, Cuellar, L, Terroba, MC, Aller, R, Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical head and neck cancer patients. Eur J Clin Nutr 58 (2004), 1505–1508.
38. 38 de Luis, DA, Izaola, O, Cuellar, L, Terroba, MC, Martin, T, Aller, R, High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. Eur Rev Med Pharmacol Sci 13 (2009), 279–283.
39. 39 Okabayashi, T, Nishimori, I, Sugimoto, T, et al. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol 23 (2008), 1869–1873.
40. 40 Byrne, DJ, Napier, A, Cuschieri, A, Prevention of postoperative wound infection in clean and potentially contaminated surgery. A prospective, randomised, double-blind, placebo-controlled clinical trial. Surg Res Commun 12 (1992), 43–52.
41. 41 Lynch, W, Davey, PG, Malek, M, Byrne, DJ, Napier, A, Cost-effectiveness analysis of the use of chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis. J Hosp Infect 21 (1992), 179–191.
42. 42 Rotter, ML, A placebo-controlled trial of the effect of two preoperative baths or showers with chlorhexidine detergent on postoperative wound infection rates. J Hosp Infect 12 (1988), 137–138.
43. 43 Earnshaw, JJ, Berridge, DC, Slack, RC, Makin, GS, Hopkinson, BR, Do preoperative chlorhexidine baths reduce the risk of infection after vascular reconstruction?. Eur J Vasc Surg 3 (1989), 323–326.
44. 44 Hayek, LJ, Emerson, JM, Preoperative whole body disinfection—a controlled clinical study. J Hosp Infect 11:suppl B (1988), 15–19.
45. 45 Randall, PE, Ganguli, LA, Keaney, MG, Marcuson, RW, Prevention of wound infection following vasectomy. Br J Urol 57 (1985), 227–229.
46. 46 Veiga, DF, Damasceno, CA, Veiga-Filho, J, et al. Randomized controlled trial of the effectiveness of chlorhexidine showers before elective plastic surgical procedures. Infect Control Hosp Epidemiol 30 (2009), 77–79.
47. 47 Ayliffe, GA, Noy, MF, Babb, JR, Davies, JG, Jackson, J, A comparison of pre-operative bathing with chlorhexidine-detergent and non-medicated soap in the prevention of wound infection. J Hosp Infect 4 (1983), 237–244.
48. 48 Leigh, DA, Stronge, JL, Marriner, J, Sedgwick, J, Total body bathing with ‘Hibiscrub' (chlorhexidine) in surgical patients: a controlled trial. J Hosp Infect 4 (1983), 229–235.
49. 49 Graling, PR, Vasaly, FW, Effectiveness of 2% CHG cloth bathing for reducing surgical site infections. AORN J 97 (2013), 547–551.
50. 50 Johnson, AJ, Daley, JA, Zywiel, MG, Delanois, RE, Mont, MA, Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty 25:suppl (2010), 98–102.
51. 51 Johnson, AJ, Kapadia, BH, Daley, JA, Molina, CB, Mont, MA, Chlorhexidine reduces infections in knee arthroplasty. J Knee Surg 26 (2013), 213–218.
52. 52 Kluytmans, J, van Belkum, A, Verbrugh, H, Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997), 505–520.
53. 53 Hetem, DJ, Bootsma, MC, Bonten, MJ, Prevention of surgical site infections: decontamination with mupirocin based on preoperative screening for Staphylococcus aureus carriers or universal decontamination?. Clin Infect Dis 62 (2016), 631–636.
54. 54 Septimus, EJ, Schweizer, ML, Decolonization in prevention of health care-associated infections. Clin Microbiol Rev 29 (2016), 201–222.
55. 55 Bode, LG, Kluytmans, JA, Wertheim, HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362 (2010), 9–17.
56. 56 Tai, YJ, Borchard, KL, Gunson, TH, Smith, HR, Vinciullo, C, Nasal carriage of Staphylococcus aureus in patients undergoing Mohs micrographic surgery is an important risk factor for postoperative surgical site infection: a prospective randomised study. Australas J Dermatol 54 (2013), 109–114.
57. 57 Konvalinka, A, Errett, L, Fong, IW, Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 64 (2006), 162–168.
58. 58 García, AM, Villa, MV, Escudero, ME, et al. Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections. Biomedica 23 (2003), 173–179 (in Spanish).
59. 59 Perl, TM, Cullen, JJ, Wenzel, RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002), 1871–1877.
60. 60 Kalmeijer, MD, Coertjens, H, van Nieuwland-Bollen, PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35 (2002), 353–358.
61. 61 Barrera, EA, Cid, BH, Bannura, CG, Contreras, RJ, Zúñiga, TC, Mansilla, EJ, Usefulness of anterograde mechanical bowel cleansing in elective colorectal surgery. Results of a prospective randomised study. Rev Chil Cir 64 (2012), 373–377 (in Spanish).
62. 62 Bretagnol, F, Panis, Y, Rullier, E, et al. Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 252 (2010), 863–868.
63. 63 Bucher, P, Gervaz, P, Soravia, C, Mermillod, B, Erne, M, Morel, P, Randomized clinical trial of mechanical bowel preparation versus no preparation before elective left-sided colorectal surgery. Br J Surg 92 (2005), 409–414.
64. 64 Burke, P, Mealy, K, Gillen, P, Joyce, W, Traynor, O, Hyland, J, Requirement for bowel preparation in colorectal surgery. Br J Surg 81 (1994), 907–910.
65. 65 Contant, CM, Hop, WC, van't Sant, HP, et al. Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial. Lancet 370 (2007), 2112–2117.
66. 66 Espin-Basany, E, Sanchez-Garcia, JL, Lopez-Cano, M, et al. Prospective, randomised study on antibiotic prophylaxis in colorectal surgery. Is it really necessary to use oral antibiotics?. Int J Colorectal Dis 20 (2005), 542–546.
67. 67 Fa-Si-Oen, P, Roumen, R, Buitenweg, J, et al. Mechanical bowel preparation or not? Outcome of a multicenter, randomized trial in elective open colon surgery. Dis Colon Rectum 48 (2005), 1509–1516.
68. 68 Horie, T, Randomized controlled trial on the necessity of chemical cleaning as preoperative preparation for colorectal cancer surgery. Dokkyo J Med Sci 34 (2007), 205–212.
69. 69 Ishida, H, Yokoyama, M, Nakada, H, Inokuma, S, Hashimoto, D, Impact of oral antimicrobial prophylaxis on surgical site infection and methicillin-resistant Staphylococcus aureus infection after elective colorectal surgery. Results of a prospective randomized trial. Surg Today 31 (2001), 979–983.
70. 70 Jung, B, Påhlman, L, Nyström, PO, Nilsson, E, Mechanical Bowel Preparation Study Group. Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. Br J Surg 94 (2007), 689–695.
71. 71 Kobayashi, M, Mohri, Y, Tonouchi, H, Miki, C, Nakai, K, Kusunoki, M, Randomized clinical trial comparing intravenous antimicrobial prophylaxis alone with oral and intravenous antimicrobial prophylaxis for the prevention of a surgical site infection in colorectal cancer surgery. Surg Today 37 (2007), 383–388.
72. 72 Lewis, RT, Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg 45 (2002), 173–180.
73. 73 Miettinen, RP, Laitinen, ST, Mäkelä, JT, Pääkkönen, ME, Bowel preparation with oral polyethylene glycol electrolyte solution vs no preparation in elective open colorectal surgery: prospective, randomized study. Dis Colon Rectum 43 (2000), 669–675.
74. 74 Oshima, T, Takesue, Y, Ikeuchi, H, et al. Preoperative oral antibiotics and intravenous antimicrobial prophylaxis reduce the incidence of surgical site infections in patients with ulcerative colitis undergoing IPAA. Dis Colon Rectum 56 (2013), 1149–1155.
75. 75 Pena-Soria, MJ, Mayol, JM, Anula, R, Arbeo-Escolar, A, Fernandez-Represa, JA, Single-blinded randomized trial of mechanical bowel preparation for colon surgery with primary intraperitoneal anastomosis. J Gastrointest Surg 12 (2008), 2103–2108.
76. 76 Ram, E, Sherman, Y, Weil, R, Vishne, T, Kravarusic, D, Dreznik, Z, Is mechanical bowel preparation mandatory for elective colon surgery? A prospective randomized study. Arch Surg 140 (2005), 285–288.
77. 77 Roos, D, Dijksman, LM, Oudemans-van Straaten, HM, de Wit, LT, Gouma, DJ, Gerhards, MF, Randomized clinical trial of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery. Br J Surg 98 (2011), 1365–1372.
78. 78 Sadahiro, S, Suzuki, T, Tanaka, A, et al. Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection: prospective randomized trial. Surgery 155 (2014), 493–503.
79. 79 Santos, JC Jr, Batista, J, Sirimarco, MT, Guimarães, AS, Levy, CE, Prospective randomized trial of mechanical bowel preparation in patients undergoing elective colorectal surgery. Br J Surg 81 (1994), 1673–1676.
80. 80 Stellato, TA, Danziger, LH, Gordon, N, et al. Antibiotics in elective colon surgery. A randomized trial of oral, systemic, and oral/systemic antibiotics for prophylaxis. Am Surg 56 (1990), 251–254.
81. 81 Takesue, Y, Yokoyama, T, Akagi, S, et al. A brief course of colon preparation with oral antibiotics. Surg Today 30 (2000), 112–116.
82. 82 Taylor, EW, Lindsay, G, Selective decontamination of the colon before elective colorectal surgery. West of Scotland Surgical Infection Study Group. World J Surg 18 (1994), 926–931.
83. 83 Young Tabusso, F, Celis Zapata, J, Berrospi Espinoza, F, Payet Meza, E, Ruiz Figueroa, E, Mechanical preparation in elective colorectal surgery, a usual practice or a necessity?. Rev Gastroenterol Peru 22 (2002), 152–158 (in Spanish).
84. 84 Zmora, O, Mahajna, A, Bar-Zakai, B, et al. Colon and rectal surgery without mechanical bowel preparation: a randomized prospective trial. Ann Surg 237 (2003), 363–367.
85. 85 Thur de Koos, P, McComas, B, Shaving versus skin depilatory cream for preoperative skin preparation. A prospective study of wound infection rates. Am J Surg 145 (1983), 377–378.
86. 86 Goëau-Brissonnière, O, Coignard, S, Merào, AP, Haicault, G, Sasako, M, Patel, JC, Preoperative skin preparation. A prospective study comparing a depilatory agent in shaving. Presse Med 16 (1987), 1517–1519 (in French).
87. 87 Abouzari, M, Sodagari, N, Hasibi, M, Behzadi, M, Rashidi, A, Re: Nonshaved cranial surgery in black Africans: a short-term prospective preliminary study (Adeleye and Olowookere, Surg Neurol 2008; 69–72) Effect of hair on surgical wound infection after cranial surgery: a 3-armed randomized clinical trial. Surg Neurol 71 (2009), 261–262.
88. 88 Adisa, AO, Lawal, OO, Adejuyigbe, O, Evaluation of two methods of preoperative hair removal and their relationship to postoperative wound infection. J Infect Dev Ctries 5 (2011), 717–722.
89. 89 Alexander, JW, Fischer, JE, Boyajian, M, Palmquist, J, Morris, MJ, The influence of hair-removal methods on wound infections. Arch Surg 118 (1983), 347–352.
90. 90 Balthazar, ER, Colt, JD, Nichols, RL, Preoperative hair removal: a random prospective study of shaving versus clipping. South Med J 75 (1982), 799–801.
91. 91 Celik, SE, Kara, A, Does shaving the incision site increase the infection rate after spinal surgery?. Spine 32 (2007), 1575–1577.
92. 92 Court-Brown, CM, Preoperative skin depilation and its effect on postoperative wound infections. J R Coll Surg Edinb 26 (1981), 238–241.
93. 93 Grober, ED, Domes, T, Fanipour, M, Copp, JE, Preoperative hair removal on the male genitalia: clippers vs razors. J Sex Med 10 (2013), 589–594.
94. 94 Horgan, MA, Kernan, JC, Schwartz, MS, Kellogg, JX, McMenomey, SO, Delashaw, JB, Shaveless brain surgery: safe, well tolerated, and cost effective. Skull Base Surg 9 (1999), 253–258.
95. 95 Ilankovan, V, Starr, DG, Preoperative shaving: patient and surgeon preferences and complications for the Gillies incision. J R Coll Surg Edinb 37 (1992), 399–401.
96. 96 Kattipattanapong, W, Isaradisaikul, S, Hanprasertpong, C, Surgical site infections in ear surgery: hair removal effect; a preliminary, randomized trial study. Otolaryngol Head Neck Surg 148 (2013), 469–474.
97. 97 Powis, SJ, Waterworth, TA, Arkell, DG, Preoperative skin preparation: clinical evaluation of depilatory cream. BMJ 2 (1976), 1166–1168.
98. 98 Rojanapirom, S, Danchaivijitr, S, Pre-operative shaving and wound infection in appendectomy. J Med Assoc Thai 75:suppl (1992), 20–23.
99. 99 Seropian, R, Reynolds, BM, Wound infections after preoperative depilatory versus razor preparation. Am J Surg 121 (1971), 251–254.
100. 100 Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 14 (2013), 73–156.
101. 101 Classen, DC, Evans, RS, Pestotnik, SL, Horn, SD, Menlove, RL, Burke, JP, The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326 (1992), 281–286.
102. 102 van Kasteren, ME, Manniën, J, Ott, A, Kullberg, BJ, de Boer, AS, Gyssens, IC, Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 44 (2007), 921–927.
103. 103 Weber, WP, Marti, WR, Zwahlen, M, et al. The timing of surgical antimicrobial prophylaxis. Ann Surg 247 (2008), 918–926.
104. 104 Steinberg, JP, Braun, BI, Hellinger, WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 250 (2009), 10–16.
105. 105 Ho, VP, Barie, PS, Stein, SL, et al. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery. Surg Infect (Larchmt) 12 (2011), 255–260.
106. 106 Koch, CG, Nowicki, ER, Rajeswaran, J, Gordon, SM, Sabik, JF 3rd, Blackstone, EH, When the timing is right: antibiotic timing and infection after cardiac surgery. J Thorac Cardiovasc Surg 144 (2012), 931–937.
107. 107 Koch, CG, Li, L, Hixson, E, et al. Is it time to refine? An exploration and simulation of optimal antibiotic timing in general surgery. J Am Coll Surg 217 (2013), 628–635.
108. 108 El-Mahallawy, HA, Hassan, SS, Khalifa, HI, El-Sayed Safa, MM, Khafagy, MM, Comparing a combination of penicillin G and gentamicin to a combination of clindamycin and amikacin as prophylactic antibiotic regimens in prevention of clean contaminated wound infections in cancer surgery. J Egypt Natl Canc Inst 25 (2013), 31–35.
109. 109 Muñoz Platón, E, Jiménez Antolín, JA, Brea Zubigaray, S, Bravo García, P, The effect of surgical antibiotic prophylaxis and the timing of its administration on the risk of surgical wound infection. Rev Clin Esp 195 (1995), 669–673 (in Spanish).
110. 110 Lizán-García, M, García-Caballero, J, Asensio-Vegas, A, Risk factors for surgical-wound infection in general surgery: a prospective study. Infect Control Hosp Epidemiol 18 (1997), 310–315.
111. 111 Trick, WE, Scheckler, WE, Tokars, JI, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 119 (2000), 108–114.
112. 112 Garey, KW, Dao, T, Chen, H, et al. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother 58 (2006), 645–650.
113. 113 Kasatpibal, N, Nørgaard, M, Sørensen, H, Schønheyder, H, Jamulitrat, S, Chongsuvivatwong, V, Risk of surgical site infection and efficacy of antibiotic prophylaxis: a cohort study of appendectomy patients in Thailand. BMC Infect Dis, 6, 2006, 111.
114. 114 WHO. WHO guidelines on hand hygiene in health care, 2009, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/44102/1/9789241597906_eng.pdf (accessed Oct 9, 2016).
115. 115 Parienti, JJ, Thibon, P, Heller, R, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA 288 (2002), 722–727.
116. 116 Nthumba, PM, Stepita-Poenaru, E, Poenaru, D, et al. Cluster-randomized, crossover trial of the efficacy of plain soap and water versus alcohol-based rub for surgical hand preparation in a rural hospital in Kenya. Br J Surg 97 (2010), 1621–1628.
117. 117 Al-Naami, MY, Anjum, MN, Afzal, MF, et al. Alcohol-based hand-rub versus traditional surgical scrub and the risk of surgical site infection: a randomized controlled equivalent trial. EWMA J 9 (2009), 5–10.
118. 118 Weight, CJ, Lee, MC, Palmer, JS, Avagard hand antisepsis vs traditional scrub in 3600 pediatric urologic procedures. Urology 76 (2010), 15–17.
119. 119 Marchand, R, Theoret, S, Dion, D, Pellerin, M, Clinical implementation of a scrubless chlorhexidine/ethanol pre-operative surgical hand rub. Can Oper Room Nurs J 26 (2008), 21–22 26, 29–31.
120. 120 Adjoussou, S, Konan Blé, R, Séni, K, et al. Value of hand disinfection by rubbing with alcohol prior to surgery in a tropical setting. Med Trop 69 (2009), 463–466 (in French).
121. 121 Bauer-Savage, J, Pittet, D, Kim, EM, Allegranzi, B, Local production of WHO-recommended alcohol-based handrubs: feasibility, advantages, barriers and costs. Bull World Health Organ 91 (2013), 963–969.
122. 122 WHO. Guide to local production: WHO-recommended handrub formulations, 2009, World Health Oganization, Geneva http://www.who.int/gpsc/5may/Guide_to_Local_Production.pdf?ua=1 (accessed Oct 9, 2016).
123. 123 Berry, AR, Watt, B, Goldacre, MJ, Thomson, JW, McNair, TJ, A comparison of the use of povidone-iodine and chlorhexidine in the prophylaxis of postoperative wound infection. J Hosp Infect 3 (1982), 55–63.
124. 124 Bibbo, C, Patel, DV, Gehrmann, RM, Lin, SS, Chlorhexidine provides superior skin decontamination in foot and ankle surgery: a prospective randomized study. Clin Orthop Rel Res 438 (2005), 204–208.
125. 125 Cheng, K, Robertson, H, St Mart, JP, Leanord, A, McLeod, I, Quantitative analysis of bacteria in forefoot surgery: a comparison of skin preparation techniques. Foot Ankle Int 30 (2009), 992–997.
126. 126 Darouiche, RO, Wall, MJ Jr, Itani, KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362 (2010), 18–26.
127. 127 Gilliam, DL, Nelson, CL, Comparison of a one-step iodophor skin preparation versus traditional preparation in total joint surgery. Clin Orthop Relat Res 250 (1990), 258–260.
128. 128 Hort, KR, DeOrio, JK, Residual bacterial contamination after surgical preparation of the foot or ankle with or without alcohol. Foot Ankle Int 23 (2002), 946–948.
129. 129 Howard, R, Comparison of a 10-minute aqueous iodophor and 2-minute water-insoluble iodophor in alcohol preoperative skin preparation. Complications Surg 10 (1991), 43–45.
130. 130 Paocharoen, V, Mingmalairak, C, Apisarnthanarak, A, Comparison of surgical wound infection after preoperative skin preparation with 4% chlohexidine and povidone iodine: a prospective randomized trial. J Med Assoc Thai 92 (2009), 898–902.
131. 131 Roberts, AJ, Wilcox, KW, Devineni, R, Harris, R, Osevala, M, Skin preparation in CABG surgery: a prospective randomized trial. Complications Surg 14 (1995), 741–747.
132. 132 Rodrigues, AL, Simões Mde, L, Incidence of surgical site infection with pre-operative skin preparation using 10% polyvidone-iodine and 0·5% chlorhexidine-alcohol. Rev Col Bras Cir 40 (2013), 443–448.
133. 133 Saltzman, MD, Nuber, GW, Gryzlo, SM, Marecek, GS, Koh, JL, Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg (Am) 91 (2009), 1949–1953.
134. 134 Savage, JW, Weatherford, BM, Sugrue, PA, et al. Efficacy of surgical preparation solutions in lumbar spine surgery. J Bone Joint Surg (Am) 94 (2012), 490–494.
135. 135 Segal, CG, Anderson, JJ, Preoperative skin preparation of cardiac patients. AORN J 76 (2002), 821–828.
136. 136 Sistla, SC, Prabhu, G, Sistla, S, Sadasivan, J, Minimizing wound contamination in a ‘clean' surgery: comparison of chlorhexidine-ethanol and povidone-iodine. Chemotherapy 56 (2010), 261–267.
137. 137 Srinivas, A, Kaman, L, Raj, P, et al. Comparison of the efficacy of chlorhexidine gluconate versus povidone iodine as preoperative skin preparation for the prevention of surgical site infections in clean-contaminated upper abdominal surgeries. Surg Today 45 (2015), 1378–1384.
138. 138 Tuuli, MG, Liu, J, Stout, MJ, et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 374 (2016), 647–655.
139. 139 Veiga, DF, Damasceno, CA, Veiga-Filho, J, et al. Povidone iodine versus chlorhexidine in skin antisepsis before elective plastic surgery procedures: a randomized controlled trial. Plast Reconstr Surg 122 (2008), 170e–171e.
140. 140 Daeschlein, G, Napp, M, Assadian, O, et al. Influence of preoperative skin sealing with cyanoacrylate on microbial contamination of surgical wounds following trauma surgery: a prospective, blinded, controlled observational study. Int J Infect Dis 29 (2014), 274–278.
141. 141 Doorly, M, Choi, J, Floyd, A, Senagore, A, Microbial sealants do not decrease surgical site infection for clean-contaminated colorectal procedures. Tech Coloproctol 19 (2015), 281–285.
142. 142 Dromzee, E, Tribot-Laspière, Q, Bachy, M, Zakine, S, Mary, P, Vialle, R, Efficacy of integuseal for surgical skin preparation in children and adolescents undergoing scoliosis correction. Spine (Phila Pa 1976) 37 (2012), E1331–E1335.
143. 143 Falk-Brynhildsen, K, Söderquist, B, Friberg, O, Nilsson, U, Bacterial growth and wound infection following saphenous vein harvesting in cardiac surgery: a randomized controlled trial of the impact of microbial skin sealant. Eur J Clin Microbiol Infect Dis 33 (2014), 1981–1987.
144. 144 Iyer, A, Gilfillan, I, Thakur, S, Sharma, S, Reduction of surgical site infection using a microbial sealant: a randomized trial. J Thorac Cardiovasc Surg 142 (2011), 438–442.
145. 145 Towfigh, S, Cheadle, WG, Lowry, SF, Malangoni, MA, Wilson, SE, Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Arch Surg 143 (2008), 885–891.
146. 146 Vierhout, BP, Ott, A, Reijnen, MM, et al. Cyanoacrylate skin microsealant for preventing surgical site infection after vascular surgery: a discontinued randomized clinical trial. Surg Infect (Larchmt) 15 (2014), 425–430.
147. 147 von Eckardstein, AS, Lim, CH, Dohmen, PM, et al. A randomized trial of a skin sealant to reduce the risk of incision contamination in cardiac surgery. Ann Thorac Surg 92 (2011), 632–637.
148. 148 Waldow, T, Szlapka, M, Hensel, J, Plotze, K, Matschke, K, Jatzwauk, L, Skin sealant InteguSeal(R) has no impact on prevention of postoperative mediastinitis after cardiac surgery. J Hosp Infect 81 (2012), 278–282.